{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P10145",
      "entity_text" : "interleukin-8",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03353",
      "entity_text" : "LUBAC complex",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The SHARPINLTM peptide reduced the amount of the LUBAC complex (XREF_FIG), thereby profoundly impairing TNF-alpha-induced IkappaBa degradation, NF-kappaB activation, and secretion of the NF-kappaB target interleukin-8 (IL-8) (XREF_FIG and XREF_SUPPLEMENTARY).",
  "reading_complete" : "2020-08-08T11:50:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T11:48:10Z",
  "trigger" : "impairing",
  "evidence" : [ "LUBAC complex ( XREF_FIG ), thereby profoundly impairing TNF-alpha-induced IkappaBa degradation, NF-kappaB activation, and secretion of the NF-kappaB target interleukin-8" ],
  "pmc_id" : "6044281",
  "score" : 0
}